Roxithromycin, also known as arrow-roxithromycin, is a semi-synthetic macrolide antibiotic, which prevents bacterial growth by interfering with protein synthesis. The drug is indicated to treat certain types of bacterial infections such as pharyngitis, sinusitis, bronchitis and pneumonia, urinary and soft tissue infections, and otitis media.
Roxithromycin Market– Driver
Increasing research for new applications of roxithromycin is expected to propel growth of the roxithromycin market during the forecast period. For instance, according to a research by Otago University, New Zealand in July 2018, roxithromycin can be effective in treating myeloma, a cancer of plasma cells that usually arises in the bone marrow and is mainly associated with depletion of hemoglobin levels. The drug aids in increasing hemoglobin levels, which strongly suggests that the amount of myeloma in bone marrow has reduced. However, the drug is still under research to confirm its use in treating myeloma.
Roxithromycin Market– Restraint
Drug recalls due to failures in meeting quality standards is expected to hinder growth of the market. For instance, in July 2016, Ministry of Health, Vietnam recalled Rom-150 tablets (Roxithromycin 150mg) manufactured by Zee Laboratories and imported by Codupha Central Pharmaceutical JSC in Vietnam. The decision to recall these drugs was based on tests performed by the National Institute of Drug Quality Control.
Avail FREE Sample Research at: https://www.coherentmarketinsights.com/insight/request-sample/2257
Roxithromycin Market– Regional Analysis
On the basis of region, the global roxithromycin market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa.
North America is expected to hold dominant position in the global roxithromycin market during the forecast period. This is owing to increasing government initiatives to prevent antimicrobial resistance and growing awareness for proper use of antibiotics. For instance in March 2015, Health Canada released Federal Action Plan with rules to reduce the risk of antimicrobial resistance in Canada, which includes infection prevention and control, research and innovation in developing antibiotics, and appropriate antimicrobial use for health professionals and the public of Canada.
Asia Pacific is expected to witness significant growth in the global roxithromycin market during the forecast period. This is owing to high infectious disease burden, unregulated sales of antibiotics and poor public health infrastructure, which are leading to increasing use of antibiotics in economies such as India. For instance, according to a report published in the journal The Lancet Infectious Diseases February 2017, Low-Income and Middle-Income Countries (LMICs) of Asia Pacific such as Nepal, Pakistan, India, and Bangladesh witness significant demand for roxithromycin, owing to less stringent policies and easy availability of antibiotics over the counter.
Key players operating in the global roxithromycin market include, Hetero Healthcare Ltd., Finecure Pharmaceuticals Ltd., Zhejiang Zhenyuan Pharmaceutical Co Ltd, Johnson & Johnson Private Limited, Hygeia Laboratories Inc, Bayer AG, Allergan plc., Galderma S.A, Valeant Pharmaceutical International, and Stiefel Laboratories
Roxithromycin Market– Taxonomy
- Urinary and Soft Tissue Infections
- Respiratory Tract Infections
- Otitis media
By Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- North America
- Asia Pacific
- Latin America
- Middle East
Get Full Detailed Research of This Report at: https://www.coherentmarketinsights.com/ongoing-insight/roxithromycin-market-2257
About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.
Name: Mr. Raj Shah
Phone: US +12067016702 / UK +4402081334027